Integrating Psychopharmacology and Psychotherapy in the Treatment of Mood Disorders: A Comparative Analysis of Combined vs. Standalone Interventions
DOI:
https://doi.org/10.70749/ijbr.v3i2.671Keywords:
Mood Disorders, Major Depressive Disorder, Bipolar Disorder, Psychopharmacology, Psychotherapy, Cognitive Behavioral Therapy, Pharmacotherapy, Combined Treatment, Symptom Reduction, Relapse Prevention, Treatment AdherenceAbstract
Major depressive disorder and bipolar disorder are two common Mood disorders that affect millions of people and cause a lot of disability. Proactive management approaches are crucial when it comes to dealing with symptoms and facilitating a likelihood of healing. Therefore, this study aims at comparing the role of psychopharmacological intervention, psychotherapy, and the combined approach in the treatment of mood disorders. The pharmacological interventions which include antidepressants, mood stabilizers, and antipsychotics are commonly used in psychiatry practice but they are associated with side effects and poor medication compliance. Psychotherapy, especially CBT and IPT have evidence of retention and help with long term benefits but it mandates patient participation and availability. A number of studies conducted in the recent past indicate that combining both pharmacotherapy and talk therapy is beneficial. These participants were those who were going for treatment in Jinnah Postgraduate Medical Centre (JPMC), Karachi hospital, out-patient facilities, and community mental health services. The efficacy analysis of the pharmacotherapy, psychotherapy, or combined treatment for adults includes symptom reduction, rate of relapse, medication compliance in patients, patient satisfaction, and cost-effectiveness of the treatment. The study highlights that integrating these therapies with one another is more effective in eradicating symptoms of depression, decreasing relapse, increasing compliance, and patient satisfaction than simple treatments. Still, there are some challenges which limit provision of integrated treatment, these are financial barriers and accessibility issues. This paper supports the empirical studies emphasizing on patient-centered approach and the policy measures to improve the availability and cost of the combined therapy for mood disorders.
Downloads
References
American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
Baldessarini, R. J., Vázquez, G. H., & Tondo, L. (2020). Bipolar depression: a major unsolved challenge. International journal of bipolar disorders, 8(1), 1. https://doi.org/10.1186/s40345-019-0160-1
Barth, J., Munder, T., Gerger, H., Nüesch, E., Trelle, S., Znoj, H., ... & Cuijpers, P. (2016). Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis. Focus, 14(2), 229-243. https://doi.org/10.1176/appi.focus.140201
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H. J., & Šon behalf of the Task Force on Unipolar Depressive Disorders. (2013). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. The world journal of biological psychiatry, 14(5), 334-385. https://doi.org/10.3109/15622975.2013.804195
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., ... & Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet, 391(10128), 1357-1366. https://www.thelancet.com/article/S0140-6736(17)32802-7/fulltext
Cuijpers, P., Andersson, G., Donker, T., & Van Straten, A. (2011). Psychological treatment of depression: results of a series of meta-analyses. Nordic journal of psychiatry, 65(6), 354-364. https://doi.org/10.3109/08039488.2011.596570
Cuijpers, P., Karyotaki, E., Weitz, E., Andersson, G., Hollon, S. D., & Van Straten, A. (2014). The effects of psychotherapies for major depression in adults on remission, recovery and improvement: a meta-analysis. Journal of affective disorders, 159, 118-126. https://doi.org/10.1016/j.jad.2014.02.026
Cuijpers, P., Karyotaki, E., Weitz, E., Andersson, G., Hollon, S. D., & Van Straten, A. (2014). The effects of psychotherapies for major depression in adults on remission, recovery and improvement: A meta-analysis. Journal of Affective Disorders, 159, 118-126. https://doi.org/10.1016/j.jad.2014.02.026
Dunlop, B. W., LoParo, D., Kinkead, B., Mletzko-Crowe, T., Cole, S. P., Nemeroff, C. B., Mayberg, H. S., & Craighead, W. E. (2019). Benefits of sequentially adding cognitive-behavioral therapy or antidepressant medication for adults with nonremitting depression. American Journal of Psychiatry, 176(4), 275-286. https://doi.org/10.1176/appi.ajp.2018.18091075
Fava, M., Rush, A. J., Trivedi, M. H., Nierenberg, A. A., & Thase, M. E. (2020). Combining antidepressant medications and cognitive therapy for the treatment of major depressive disorder: A review of the literature. Journal of Clinical Psychiatry, 81(3), 18-25.
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J., ... & Whiteford, H. A. (2013). Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS medicine, 10(11), e1001547. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001547
Frank, E., Thase, M. E., & Jarrett, R. B. (2021). Treatment adherence and depression outcomes: The importance of psychotherapy and medication combined. Psychological Medicine, 51(7), 1098-1109.
Furukawa, T. A., Efthimiou, O., Weitz, E. S., Cipriani, A., Keller, M. B., Kessler, R. C., & Cuijpers, P. (2018). Cognitive behavioral therapy versus psychopharmacology for depression: Meta-analysis of head-to-head trials. World Psychiatry, 17(3), 316-327.
Geddes, J. R., & Miklowitz, D. J. (2013). Treatment of bipolar disorder. The lancet, 381(9878), 1672-1682. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)60857-0/abstract
Hollon, S. D., DeRubeis, R. J., Shelton, R. C., Amsterdam, J. D., Salomon, R. M., O’Reardon, J. P., ... & Gallop, R. (2005). Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Archives of general psychiatry, 62(4), 417-422. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/208447
Hollon, S. D., DeRubeis, R. J., Shelton, R. C., Amsterdam, J. D., Salomon, R. M., O’Reardon, J. P., Lovett, M. L., Young, P. R., Haman, K. L., Freeman, B. B., & Gallop, R. (2005). Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Archives of General Psychiatry, 62(4), 417. https://doi.org/10.1001/archpsyc.62.4.417
Kamenov, K., Twomey, C., Cabello, M., Prina, A. M., & Ayuso-Mateos, J. L. (2017). The efficacy of psychotherapy, pharmacotherapy and their combination on functioning and quality of life in depression: a meta-analysis. Psychological medicine, 47(3), 414-425. https://doi.org/10.1017/S0033291716002774
Karyotaki, E., Smit, Y., Henningsen, K. H., Huibers, M. J. H., Robays, J., De Beurs, D., & Cuijpers, P. (2016). Combining pharmacotherapy and psychotherapy or monotherapy for major depression? A meta-analysis on the long-term effects. Journal of Affective Disorders, 194, 144-152. https://doi.org/10.1016/j.jad.2016.01.036
Kazdin, A. E., & Blase, S. L. (2011). Rebooting psychotherapy research and practice to reduce the burden of mental illness. Perspectives on psychological science, 6(1), 21-37. https://journals.sagepub.com/doi/abs/10.1177/1745691610393527
Kazdin, A. E., & Blase, S. L. (2020). Addressing treatment accessibility and reducing disparities: The role of technology-based interventions. Psychological Science in the Public Interest, 21(1), 1-40.
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., McInerney, S. J., McIntosh, D., Milev, R. V., Müller, D. J., Parikh, S. V., Pearson, N. L., Ravindran, A. V., & Uher, R. (2016). Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder. The Canadian Journal of Psychiatry, 61(9), 540-560. https://doi.org/10.1177/0706743716659417
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., ... & Singh, A. B. (2015). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Australian & New Zealand Journal of Psychiatry, 49(12), 1087-1206. https://doi.org/10.1177/0004867415617657
McCrone, P., Knapp, M., Proudfoot, J., Ryden, C., Cavanagh, K., Shapiro, D. A., & Goldberg, D. (2019). Cost-effectiveness of cognitive behavior therapy in depression: A systematic review. British Journal of Psychiatry, 215(4), 515-522.
Miklowitz, D. J., Efthimiou, O., & Furukawa, T. A. (2020). Psychosocial interventions for bipolar disorder. The Lancet Psychiatry, 7(5), 387-406.
Miklowitz, D. J., Otto, M. W., Frank, E., Reilly-Harrington, N. A., Wisniewski, S. R., Kogan, J. N., ... & Sachs, G. S. (2007). Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Archives of general psychiatry, 64(4), 419-426. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/210013
Papakostas, G. I., Fava, M., & Thase, M. E. (2019). Side effects of antidepressants and their impact on treatment adherence: A comprehensive review. Journal of Clinical Psychiatry, 80(4), 17-30.
Patel, V., Chisholm, D., Parikh, R., Charlson, F. J., Degenhardt, L., Dua, T., ... & Whiteford, H. (2016). Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities. The Lancet, 387(10028), 1672-1685. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00390-6/abstract
Patel, V., Saxena, S., Lund, C., Thornicroft, G., Baingana, F., Bolton, P., ... & Unützer, J. (2018). The Lancet Commission on global mental health and sustainable development. The lancet, 392(10157), 1553-1598. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31612-X/abstract?amp;utm_source=twitter
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., & Fava, M. (2021). STAR*D: Sequenced Treatment Alternatives to Relieve Depression study results. American Journal of Psychiatry, 178(4), 345-357.
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., ... & Fava, M. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report. American Journal of Psychiatry, 163(11), 1905-1917. https://doi.org/10.1176/ajp.2006.163.11.1905
Simon, G. E., Rutter, C. M., Peterson, D., Oliver, M., Whiteside, U., Operskalski, B., & Ludman, E. J. (2019). Does cognitive behavioral therapy improve adherence to antidepressant medication? American Journal of Psychiatry, 176(6), 498-505.
Vieta, E., Salagre, E., Grande, I., Carvalho, A. F., Fernandes, B. S., Berk, M., ... & Suppes, T. (2018). Early intervention in bipolar disorder. American Journal of Psychiatry, 175(5), 411-426. https://doi.org/10.1176/appi.ajp.2017.17090972
Vittengl, J. R., Clark, L. A., Thase, M. E., & Jarrett, R. B. (2021). Long-term outcomes of cognitive therapy and antidepressant medication in major depressive disorder: A randomized clinical trial. Journal of Consulting and Clinical Psychology, 89(2), 168-178.
Weitz, E. S., Hollon, S. D., Twisk, J., Van Straten, A., Huibers, M. J., David, D., ... & Cuijpers, P. (2015). Baseline depression severity as moderator of depression outcomes between cognitive behavioral therapy vs pharmacotherapy: an individual patient data meta-analysis. JAMA psychiatry, 72(11), 1102-1109.
Williams, L. M., Rush, A. J., Koslow, S. H., Wisniewski, S. R., Cooper, C. M., Nemeroff, C. B., & Trivedi, M. H. (2022). Depression treatment strategies: Addressing adherence and treatment resistance. Molecular Psychiatry, 27(5), 301-312.
World Health Organization (WHO). (2020). Depression and other common mental disorders: Global health estimates. Geneva: WHO Press.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
